Oncology Optimism With Recent Advances in First- and Second-Line Treatment Options in Metastatic Pancreatic Cancer expert roundtables By Alok Khorana, MD; Michael Morse, MD, MHS, FACP; Thomas A. Abrams, MD
Hematology Updates on Second-Line Therapies for Immune Thrombocytopenia clinical study insights By Terry B. Gernsheimer, MD
Oncology Novel Drug Delivery Systems Metastatic Pancreatic Cancer expert roundtables By Alok Khorana, MD; Michael Morse, MD, MHS, FACP; Thomas A. Abrams, MD
Hematology Use of Combination Therapy in the Management of Chronic Immune Thrombocytopenia patient care perspectives By Adam Cuker, MD, MS
Hematology Proper Clinical Diagnosis Is Essential in Primary Immune Thrombocytopenia clinical topic updates By Howard A. Liebman, MD